Review on dermatomycosis: pathogenesis and treatment
Deepika T. Lakshmipathy, Krishnan Kannabiran
DOI: 10.4236/ns.2010.27090   PDF    HTML     15,143 Downloads   35,590 Views   Citations

Abstract

Dermatophytes, a group of keratinophilic fungi thriving on the keratin substrate are the etio-logical agents responsible for causing cutaneous infections. Dermatophytosis is currently treated with the commercially available topical and oral antifungal agents in spite of the existing side effects. Treatment of these cutaneous infections with secondary metabolites produced by marine microorganisms is considered as a novel approach. For many years these organisms have been explored with the view of developing antibacterial, antifungal, antiviral, anti- cancer and antiparasitic drugs. Exploring the unexplored aspect of actinobacteria for developing antidermatophytic drugs is a novel attempt which needs further investigation.

Share and Cite:

Lakshmipathy, D. and Kannabiran, K. (2010) Review on dermatomycosis: pathogenesis and treatment. Natural Science, 2, 726-731. doi: 10.4236/ns.2010.27090.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Emmons, C.W., Bindford, C.H., Utz, J.P. and Kwon- Chung, K.L. (1977) Dermatophytoses. Medical Mycology, 3rd Edition, Lea and Febiger, Philadelphia, 117-167.
[2] Luilma, A.G., Sidrimb, J.J.C., Domingos, T.M., Cechinel, V.F. and Vietla, S.R. (2005) In vitro antifungal activity of dragon’s blood from Croton urucurana against dermato-phytes. Journal of Ethnopharmacology, 97(2), 409-412.
[3] Pinto, E., Pina-Vaz, C., Salgueiro, L., Goncalves, M.J., Costa-de-Oliveira, S., Carlos, C., Palmeira, A., Rodrigues, A. and Martinez-de-Oliveira, J. (2006) Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species. Journal of Medical Microbiology, 55(10), 1367-1373.
[4] Naveed, A.M., Naeem, R. and Nasiruddin (2009) Non- dermatophyte moulds and yeasts as causative agents in Onychomycosis. Journal of Pakistan Association of Der- matologists, 19(2), 74-78.
[5] Rippon, J.W. (1988) The Pathogenic Fungi and Patho-genic Actionmycetes, 3rd Edition. WB Saunders, Phila-delphia, 1988.
[6] Rao, A. (1959) Mycotic diseases in India - a critical review. Bulletin of School of Tropical Medicine Calcutta, 13-22.
[7] Georg, L.K. (1959) Animals ringworm in public health. Diagnosis and Nature, Bulletin, 57.
[8] Rippon, J.W. (1982) Host specificity in dermatophytoses. Proceedings of the Eight Congress of the International Society for Human and Animal Mycology, 28-33.
[9] De Vroey, C. (1984) Ecological and epidemiological aspects in dermatophytoses. Zbl Bakt Hyg., 257(2), 234- 239.
[10] Baxter, M. and Pearson, R.D. (1969) The occurence of Microsporum nanumas a human pathogen and animal pathogen in New Zealand. New Zealand Journal of Medical Laboratory Technology, 23, 87-90.
[11] Connole, M.D. (1990) Review of animal mycoses in Australia. Mycopathologia, 111(3), 133-164.
[12] English, M.P. (1972) The epidemiology of animal ring-worm in man. British Journal of Dermatology, 86(3), 78-87.
[13] Marples, M.J. (1956) The ecology of Microsporum canis bodin in New Zealand. Journal of Hygiene, 54(3), 378-387.
[14] Georg, L.K. (1960) Epidemiology of dermatophytes sources of infection, modes of transmission and epide-micity. Annals of the New York Academy of Sciences, 89(2-3), 69-77.
[15] Kaplan, W. and Gump, R.H. (1958) Ringworm in the dog caused by Trichophyton rubrum. Veterinary Medicine, 53(1), 139-142.
[16] Jagdish, C. (1995) Dermatophytoses. Medical Mycology, 1st Etdition, 106-107.
[17] Wagner, D.K. and Sohnle, P.G. (1995) Cutaneous de-fenses against dermatophytes and yeasts. Clinical Micro-biology Reviews, 8(3), 317-335.
[18] Larone, D.H. (1995) Medically important fungi: A guide to identification, 3rd Edition, American Society for Mi-crobiology.
[19] Philpot, C.M. (1977) Use of nutritional tests for the dif-ferentiation of dermatophytes. Sabouraudia, 15(2), 141- 150.
[20] Emmons, C.W. (1934) Dermatophytes-natural grouping based on the form of the spores and accessory organs. Arch Dermatol Syphil, 30(3), 337-362.
[21] St-Getmain, G. and Summerbell, R. (1996) Identifying filamentous fungi: A clinical laboratory handbook. Star Publishing, Belmont.
[22] Chen, B.K. and Friedlander, S.F. (2001) Tinea capitis update: A continuing conflict with an old adversary. Current Opinion in Pediatrics, 13(4), 331-335.
[23] Ciavaglia, M.C., de Carvalho, T.U. and de Souza, W. (1993) Interaction of trypanosoma cruzi with cells with altered glycosylation patterns. Biochemical and Biophys-ical Research Communication, 193(2), 718-721.
[24] Coloe, S.V. and Baird, R.W. (1999) Dermatophyte infec-tions in Melbourne: Trends from 1961/64 to 1995/96. Pathology, 31(4), 395-397.
[25] Marques, S.A., Robles, A.M., Tortorano, A.M., Tuculet, M.A., Negroni, R. and Mendes, R.P. (2000) Mycoses as-sociated with AIDS in the Third World. Medical Mycology, 38(Suppl. 1), 269-279.
[26] Vander Straten, M.R., Hossain, M.A. and Ghannoum, M.A. (2003) Cutaneous Infections dermatophytosis, onychomycosis, and tinea versicolor. Infectious Disease Clinics of North America, 17(1), 87-112.
[27] Weirzman, I. and Summerbell, R.C. (1995) The derma-tophytes. Clinical Microbiology Reviews, 8(2), 240- 259.
[28] Wawrzkiewicz, K., Wolski, T. and Lobarzewski, J. (1991) Screening the keratinolytic activity of dermatophytes in vitro. Mycopathologia, 114(3), 1-8.
[29] Lopez-Martinez, R., Manzano-Gayosso, P., Mier, T., Mendez-Tovar, L.J. and Hernandez-Hernandez, F. (1994) Exoenzymes of dermatophytes isolated from acute and chronic tinea. Revista Latinoamericana de Microbiología, 36(1), 17-20.
[30] Siesenop, U. and Bohm, H. (1995) Comperative studies on keratinase production of Trichophyton mentagrophytes strains of animal origin. Mycoses, 38(5-6), 205- 209.
[31] Muhsin, T.M., Aubaid, A.H. and Al-Duboon, A.H. (1997) Extracellular enzyme activities of dermatophytes and yeast isolates on solid media. Mycoses, 40(11-12), 465-469.
[32] Dahl, M.V. (1994) Dermatophytosis and immune re-sponse. Journal of the American Academy of Dermatol-ogy, 31(3), S34-S41.
[33] Theodore, C.W., Brian, G.O., Yvonne, G. and Matthew, R.H. (2008) Generating and testing molecular hypotheses in the dermatophytes. Eukaryotic Cell, 7(8), 1238-1245.
[34] Judith, A.W. (2005) Allergy and dermatophytes. Clinical Microbiology Reviews, 30-43.
[35] Grappel, S.F., Bishop, C.T. and Blank, F. (1974) Immu-nology of dermatophytes and dermatophytosis. Bacteri-ology Reviews, 38(3), 222-250.
[36] Berdy, J. (1989) The discovery of new bioactive microbial metabolites: Screening and identification. In: Bioactive Metabolites from Microorganisms, Bushell, M.E., Grafe, U., Eds., Elsevier, Amsterdam, 3-25.
[37] Elewski, B.E. and Hazen, P.G. (1989) The superficial mycoses and the dermatophytes. Journal of the American Academy of Dermatology, 21(4), 655-673.
[38] Pavithran, K. (1985) Fungal infections of the skin. Der-mato-Venero-Leprology, 77.
[39] Pasricha, J.S. (1981) Infections and infestations. Treat-ment of Skin Diseases, 82(1), 73-74.
[40] Elewski, B.E. (1993) Mechanisms of action of systemic antifungal agents. Journal of the American Academy of Dermatology, 28(3), 28-34.
[41] Michael, A.P. and Deanna, A.S. (2006) Review of in vitro activity of sertaconazole nitrate in the treatment of super-ficial fungal infections. Diagnostic Microbiology Infec-tious Disease, 56(4), 147-152.
[42] Van Cutsem, J.M. and Thienpont, D. (1972) Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy, 17(1), 392-404.
[43] Agut, J., Palac?′n, C., Salgado, J., Casas, E., Sacrista′n, A. and Ortiz, J.A. (1992) Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity. Arzneimittelforschung, 42(5A), 721-724.
[44] Katsambas, A., Antoniou, C.H., Frangouli, E., Avgerinou, G., Michailidis, D. and Stratigos, J. (1989) A double- blind trial of treatment of seborrhoic dermatitis with 2% ketaconazole cream compared with 1% hydrocortisone cream. British Journal of Dermatology, 12(Suppl 14), 353-357.
[45] Grant, S.M. and Clissold, S.P. (1989) Itraconazole: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in superficial and systemic mycosis. Drugs, 37(3), 310-344.
[46] Wolverton, S.E. (2001) Systemic antifungal drugs. Com-prehensive Dermatologic Drug Therapy, 2nd Edition, Saunders.
[47] Andriole, V.T. (2000) Current and future antifungal ther-apy: New targets for antifungal therapy. International Journal of Antimicrobial Agents, 16(3), 317-322.
[48] Lieven, M., Jef, V.G., Frans, V.G., Filip, W., Patrick, M., Vic, S., Gilkerson, T., Roger, N., David, C. and Richardsc, R.D. (2005) Pyrrolo[1,2-a][1,4]benzodiazepine: A novel class of non-azole anti-dermatophyte anti-fungal agents. Bioorganic & Medicinal Chemistry Letters, 15(14), 3453-3458.
[49] Oxford, A.E., Raistruck, H. and Simonarat, P. (1939) Studies in the biochemistry of microorganisms, Griseo-fulvin CHOCI, a metabolic product of Penicillium gri- seofulvin dierck. Biochemistry, 33(2), 248-252.
[50] Gentles, J.C. (1958) Experimental ringworm of guinea pigs: Oral treatment with griseofulvin. Nature, 182(4633), 476-477.
[51] Rajendra, P.N., Anandi, C., Balasubramanian, S. and Pugalendi, K.V. (2004) Antidermatophytic activity of ex-tracts from Psoralea corylifolia (Fabaceae) correlated with the presence of a flavonoid compound. Journal of Ethnopharmacology, 91(1), 21-24.
[52] Natarajan, V., Venugopal, P.V. and Menon, T. (2003) Effect of Azadirachta indica (Neem) on the growth pattern of dermatophytes. Indian Journal of Medical Micro-biology, 21(2), 98-101.
[53] Nenoff, P., Haustein, U.F. and Brandt, W. (1996) Anti-fungal activity of essential oil of Melaleuca alternifolia against pathogenic fungi in vitro. Skin Pharmacology, 9(6), 388-394.
[54] Vivek, K.B., Jung, I.Y. and Sun, C.K. (2009) Antifungal potential of essential oil and various Organic extracts of Nandina domestica Thunb against skin infectious fungal pathogens. Applied Microbiology and Biotechnology, 83(6), 1127-1133.
[55] Helena, G., Sonia, S.F., Ana, I.R. and Rob, V.S. (2004) Antifungal activity of (+) -curcuphenol, a metabolite from the marine sponge didiscus oxeata. Marine Drugs, 2(1), 8-13.
[56] Deepika, T.L. and Kannabiran, K. (2009) A morphological, biochemical and biological studies of halophilic Streptomyces sp isolated from saltpan environment. American Journal of Infectious Diseases, 5(3), 207- 213.
[57] Deepika, T.L. and Kannabiran, K. (2009) A report on antidermatophytic activity of actinomycetes isolated from Ennore coast of Chennai, Tamil Nadu, India. International Journal of Integrative Biology, 6(3), 132-136.
[58] Vijayakumar, R., Muthukumar, C., Thajuddin, N., Pan-neerselvam, A. and Saravanamuthu, R. (2007) Studies on the diversity of actinomycetes in the Palk Strait region of Bay of Bengal, India. Actinomycetologica, 21(2), 59-65.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.